...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Not good for the potential of apabetalone as a Covid-19 therapy

Thanks Bear! 

You are so helpful and it is much appreciated.

Sorry, just one more thing.   I take it your point is that even this statement,

"We observed a marked improvement in mortality, whereby all INCB054329-treated mice survived after 24 h of the LPS-challenge, compared with only 25% in the control group",

still did not really reflect improved survival, because it was only 24 hour survival and all the affected mice died or were euthanized anyway?

Is that correct?

Share
New Message
Please login to post a reply